Download EAU Programme
Total Page:16
File Type:pdf, Size:1020Kb
Table of Contents Welcome by the EAU Secretary General 2 Welcome by the EAU Congress President 3 EAU patrons and contributors 4 Synopsis 6 General Floorplans congress venue 17 General information 20 Speakers’ guidelines 24 Social programme 25 Excursions 26 About Paris 28 Congress hotel listing 31 Programme Wednesday, 5 April 35 Programme Thursday, 6 April 89 Programme Friday, 7 April 175 Programme Saturday, 8 April 263 ESU Courses and Hands-on training sessions ESU courses 271 ESU/ESUT hands-on laparoscopy courses 308 Hands-on training sessions 312 EAU Section meetings 315 European Society of Residents in Urology (ESRU) Programme 335 European Assocation of Urology Nurses (EAUN) Programme 337 About EAU of Contents Table EAU Membership 343 EAU Offices 344 European Urology Accredited Medical Education Programme 346 Continuing Medical Education - Accreditation points national urological associations 347 Historical overview EAU Congresses 348 Indexes DVD library 350 List of abstract authors and presenters 380 List of abstracts sorted by topic 408 List of sessions sorted by topic 411 List of speakers (not abstracts) 412 1 Welcome to Paris Dear Colleagues, Bienvenue à Paris! It is a tremendous honour and pleasure to welcome you to my home city for the 21st Annual EAU Congress from 5-8 April 2006. It is 10 years since the EAU Congress was held in Paris and in that interim period the EAU has grown into a multi-faceted professionally renowned organisation. The 21st Annual EAU Congress will provide a platform for you to interact with your colleagues, will stimulate and create an exchange of ideas and will be personally rewarding. As professionals in the field of urology we are constantly striving to increase our Prof. Pierre Teillac knowledge and with this in mind the EAU Scientific Committee have compiled an EAU Secretary General exciting and varied programme. The high-quality scientific programme will open new perspectives on issues related to treatment and patient care. The plenary sessions and core symposia will indeed provide you with a full update on the most important aspects and latest achievements in urology. The Congress will also serve the educational mission of the EAU through a variety of courses and hands-on training sessions organised by the European School of Urology (ESU). The Congress will be fully accredited by the EU-ACME (European Urology - Accredited Continuing Medical Education). To coincide with the scientific programme, an extensive commercial exhibition will be held where companies and suppliers will exhibit their newest innovations. Your participation in this Congress will also be an opportunity for you to discover, or rediscover, Paris – City of Light. Paris is a city of art and theatre, of The Eiffel Tower and Notre Dame, of the Champs Elysées and the Canal St-Martin, of nightclubs and the Moulin Rouge - never a dull moment in this historic, romantic and bustling city. I look forward to welcoming old friends and meeting new ones in what promises to be a successful and memorable Congress! 2 Dear colleagues, It is a great pleasure for me to welcome you to Paris for the 21st Annual EAU Congress. The Annual EAU Congress is one of the most important events of our association and it is only with the dedication of many people that a medical congress of this magnitude and diversity can be realised. This programme book is the result of the commitment of the EAU Scientific Office together with all those people who have directly contributed or who are taking part in the programme. The aims of the programme are twofold: Prof. Laurent Boccon-Gibod Firstly, the plenary and sub-plenary sessions will deliver up-to-date scientific President 21st Annual EAU Congress information to delegates engaged in clinical practice, providing a full update on the latest developments in the field of urology which clearly indicates what can be achieved or utilised and what remains debatable. Secondly, the abstract sessions are a platform to foster scientific exchanges and discussions between clinician-researchers, based on recently concluded work or work in progress. The plenary and sub-plenary programme is the culmination of the hard work of the EAU Scientific Office under the guidance of Professor F. Hamdy. Leafing through the programme book, you will find that ‘no (urological) stone has been left unturned’ and that the majority of the questions of the day will be addressed, if not answered. One of the measures of a successful congress is through its scientific submissions and these are the direct result of your personal energetic input. The Paris Congress sets a new record for abstract submissions with more than 3.200 abstracts being submitted. You can be assured that reviewers and members of the EAU Scientific Office have done their best to compile a marvelous programme, the only regret being that they were unable to accept more papers due to time and space constraints. I wish you an excellent 2006 EAU Congress in Paris. Welcome to Paris Welcome 3 EAU Patrons and Contributors The European Association of Urology respectfully acknowledges the EAU Corporate Sponsors and all other sponsors for providing educational grants and services to the 21st Annual EAU Congress EAU Platinum Corporate sponsors ASTELLAS BOEHRINGER INGELHEIM GMBH/ELI LILLY & COMPANY GLAXOSMITHKLINE LILLY ICOS LLC MSD NOVARTIS PHARMA AG/NOVARTIS ONCOLOGY PFIZER INC PIERRE FABRE MÉDICAMENT SANOFI-AVENTIS EAU Gold Corporate sponsors BAYER HEALTHCARE AG BOEHRINGER INGELHEIM GMBH IPSEN KARL STORZ GMBH & CO.KG SANOFI PASTEUR Congress Contributors ABBOTT MOLECULAR ASTRAZENECA BOSTON SCIENTIFIC EDAP GEN-PROBE INCORPORATED LUMENIS GMBH STEBA BIOTECH/NEGMA UCB PHARMA 4 5 Wednesday, 5 April Level 1 Level 2 Level 3 eURO Room Room Room Room Room Room Room Auditorium Ternes Blue Maillot 242 251 252 Bordeaux 08.00 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-13.45 EAU Section EAU Section EAU Section EAU Section EAU Section EAU Section meeting meeting meeting meeting meeting meeting 09.00 ESOU ESFU ESGURS ESNU ESUI ESUT Uro-oncological Update on Reconstructive Introducing the Innovative What’s new in 10.00 surgery: Tricks female urology surgery of the second European imaging in and uro-technology? and techniques pelvis masterclass on around urology Botulinum EORTC toxin for the 11.00 GU-group overactive bladder From clinical trials to patient care 12.00 page 316 page 315 page 322 page 328 page 330 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 13.00 Video Poster Oral Poster Poster Poster Poster Session 1 Session 1 Session 1 Session 2 Session 3 Session 4 Session 5 Surgical anatomy Sexual function Urothelial Kidney tumours: Research and drug Urothelial Basic research in laparoscopic and dysfunction: tumours: Basic research therapy for stone tumours: Basic developments in page 334 radical Basic research Management of disease research I female urology prostatectomy infiltrative/ 14.00 advanced tumours I V1-V6 9-23 1-8 24-38 39-53 54-68 69-83 page 38 page 40 page 39 page 42 page 44 page 46 page 48 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 15.00 Video Poster Oral Poster Poster Poster Poster Oral Session 2 Session 10 Session 2 Session 11 Session 12 Session 13 Session 14 Session 3 Advances in Ejaculatory Urological Kidney tumours: Update on Urothelial Non-neurogenic Prostate cancer laparoscopic pelvic dysfunction: Basic reconstruction I Diagnosis and ureteroscopy and tumours: Basic voiding stem cells surgery and clinical staging I stents research II dysfunction: The research bladder factor V7-V12 161-175 145-151 176-190 191-205 206-220 221-235 153-160 page 58 page 62 page 59 page 64 page 66 page 68 page 70 page 61 16.00 16.15-17.45 16.15-17.45 16.15-17.45 16.15-17.45 16.15-17.45 Symposium Symposium Symposium Symposium Symposium Managing the Helping couples Advancing the Vascular-targeted Prostate cancer LUTS/BPH patient: stay connected - management of photodynamic prevention: The impact of new paradigms in OAB: New data, therapy with A relevant nocturia ED management new directions Tookad (VTP) for therapeutic the treatment of target for patients localised prostate with BPH 17.00 cancer ASTELLAS/ BOEHRINGER BAYER STEBA BIOTECH/ INGELHEIM HEALTHCARE AG PFIZER INC NEGMA MSD page 80 page 81 page 82 page 85 page 83 18.00 18.15-21.00 19.00 Opening Ceremony & 20.00 Welcome Cocktail page 88 21.00 6 Wednesday, 5 April Level 3 Level 4 Room Room Room Room Room Room Room Room Room Room Havana 341 342 343 351 353 352 Concorde 1 Concorde 2 Concorde 3 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.00 08.30-12.30 08.00 EAU Section EAU Section EAU Section EAU Section EAU Section EAU/CAU EAU Section meeting meeting meeting meeting meeting joint Session meeting 09.00 ESIU ESUP ESTU ESUR ESAU 09.30-11.00 eULIS Difficult Morphological Controversies ‘...omics in What’s new in ISSAM Session Difficult cases infections in changes in in immuno- urological andrology? An of urolithiasis: 10.00 urology prostate tissue suppression disease’ old head on Testosterone Medical and following the and hot topics young and male surgical various forms in renal shoulders aging in solutions of treatment transplan- urological 11.00 tation practice page 37 page 35 page 324 page 333 page 320 page 332 page 318 page 326 12.00 12.30-18.00 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 13th ESRU 13.00 Poster Meeting Poster Poster Poster Session 6 Session 7 Session 8 Session 9 Urethral Prostate Laparoscopic